Your browser doesn't support javascript.
loading
Cancer risk among insulin users: comparing analogues with human insulin in the CARING five-country cohort study.
But, Anna; De Bruin, Marie L; Bazelier, Marloes T; Hjellvik, Vidar; Andersen, Morten; Auvinen, Anssi; Starup-Linde, Jakob; Schmidt, Marjanka K; Furu, Kari; de Vries, Frank; Karlstad, Øystein; Ekström, Nils; Haukka, Jari.
Afiliación
  • But A; Department of Public Health Clinicum, University of Helsinki, Tukholmankatu 8B, P.O. Box 20, 00014, Helsinki, Finland. anna.but@helsinki.fi.
  • De Bruin ML; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, the Netherlands. M.L.deBruin@uu.nl.
  • Bazelier MT; Copenhagen Centre for Regulatory Science (CORS), Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark. M.L.deBruin@uu.nl.
  • Hjellvik V; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Universiteitsweg 99, 3584 CG, Utrecht, the Netherlands.
  • Andersen M; Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway.
  • Auvinen A; Centre for Pharmacoepidemiology, Karolinska Institutet, Stockholm, Sweden.
  • Starup-Linde J; Research Unit of General Practice, University of Southern Denmark, Odense, Denmark.
  • Schmidt MK; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
  • Furu K; Department of Epidemiology, School of Health Sciences, University of Tampere, Tampere, Finland.
  • de Vries F; Department of Endocrinology and Internal Medicine, Aarhus University Hospital THG, Aarhus, Denmark.
  • Karlstad Ø; Division of Molecular Pathology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Ekström N; Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Haukka J; Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway.
Diabetologia ; 60(9): 1691-1703, 2017 Sep.
Article en En | MEDLINE | ID: mdl-28573394
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Insulina / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Año: 2017 Tipo del documento: Article País de afiliación: Finlandia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Insulina / Neoplasias Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Año: 2017 Tipo del documento: Article País de afiliación: Finlandia